Dow Up0.48% Nasdaq Up0.43%

ImmunoGen, Inc. (IMGN)

11.79 Aug 19, 4:00PM EDT
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.5
Mean Recommendation (last week):2.5

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:15.27
Median Target:14.00
High Target:21.00
Low Target:10.00
No. of Brokers:11

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Jun 12, 2014UBSUpgradeSellNeutral
Apr 16, 2014Canaccord GenuityInitiated Buy
Sep 30, 2013Chardan Capital MarketsInitiated Buy
Jan 28, 2013OppenheimerDowngradeOutperformPerform
Sep 27, 2012UBSInitiated Sell
Aug 24, 2012Stifel NicolausInitiated Hold
Jun 14, 2012Cantor FitzgeraldInitiated Hold
Apr 8, 2011RBC Capital MktsUpgradeSector PerformOutperform
Jan 27, 2010Canaccord AdamsInitiated Buy
Oct 8, 2009Brean MurrayInitiated Buy

More Upgrades & Downgrades for IMGN

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy4455

Data provided by Thomson/First Call

Currency in USD.